Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

BGM Group Ltd. (BGM) vs Clever Leaves Holdings Inc. (CLVR)

BGM Group Ltd. and Clever Leaves Holdings Inc. are both Drug Manufacturers Specialty & Generic companies. BGM Group Ltd. and Clever Leaves Holdings Inc. are of similar size ($104.6M and $96.5M). Clever Leaves Holdings Inc. has negative trailing earnings, so its P/E is not meaningful; BGM Group Ltd. trades at 4.0×. BGM Group Ltd. has the higher net margin (1.96% vs −102.8%) and the higher return on invested capital (0.00% vs −52.6%). Across the 13 metrics below, BGM Group Ltd. leads on 8 and Clever Leaves Holdings Inc. on 5.

Valuation

Metric BGM CLVR Drug Manufacturers Specialty & Generic median
P/E 4.00 n/m 20.14
P/S n/m n/m 2.25
P/B n/m n/m 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m 0.45 12.29
EV/Sales (0.09) (0.33) 2.56
Earnings yield 25.00% 0.00% (2.99%)
Free cash flow yield 0.00% 0.00% 0.00%

Profitability

Metric BGM CLVR Drug Manufacturers Specialty & Generic median
Gross margin 6.54% 37.64% 53.94%
Operating margin 0.00% (89.53%) 0.00%
Net margin 1.96% (102.77%) 0.00%
Free cash flow margin 0.00% (49.82%) 0.00%
Return on equity 0.00% (55.39%) (0.40%)
Return on assets 0.00% (42.95%) (3.32%)
Return on invested capital 0.00% (52.59%) 0.00%

Growth

Metric BGM CLVR Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 6.14% 10.01%
EPS growth (last fiscal year) 10.00% 77.89% —
Revenue growth, 5-year CAGR (5.39%) — 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BGM CLVR Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.05 0.05
Current ratio 1.25 2.40 2.31
Net debt to EBITDA 0.97 0.45 0.85

Dividend

Metric BGM CLVR Drug Manufacturers Specialty & Generic median
Dividend yield 0.00% — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric BGM CLVR Drug Manufacturers Specialty & Generic median
Market cap 104.61m 96.49m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack